Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia

BackgroundLarge anatomical variations occur during the course of intensity-modulated radiation therapy (IMRT) for locally advanced head and neck cancer (LAHNC). The risks are therefore a parotid glands (PG) overdose and a xerostomia increase.The purposes of the study were to estimate:- the PG overdose and the xerostomia risk increase during a “standard” IMRT (IMRTstd);- the benefits of an adaptive IMRT (ART) with weekly replanning to spare the PGs and limit the risk of xerostomia.Material and methodsFifteen patients received radical IMRT (70 Gy) for LAHNC. Weekly CTs were used to estimate the dose distributions delivered during the treatment, corresponding either to the initial planning (IMRTstd) or to weekly replanning (ART). PGs dose were recalculated at the fraction, from the weekly CTs. PG cumulated doses were then estimated using deformable image registration. The following PG doses were compared: pre-treatment planned dose, per-treatment IMRTstd and ART. The corresponding estimated risks of xerostomia were also compared. Correlations between anatomical markers and dose differences were searched.ResultsCompared to the initial planning, a PG overdose was observed during IMRTstd for 59% of the PGs, with an average increase of 3.7 Gy (10.0 Gy maximum) for the mean dose, and of 8.2% (23.9% maximum) for the risk of xerostomia. Compared to the initial planning, weekly replanning reduced the PG mean dose for all the patients (p < 0.05). In the overirradiated PG group, weekly replanning reduced the mean dose by 5.1 Gy (12.2 Gy maximum) and the absolute risk of xerostomia by 11% (p < 0.01) (30% maximum). The PG overdose and the dosimetric benefit of replanning increased with the tumor shrinkage and the neck thickness reduction (p < 0.001).ConclusionDuring the course of LAHNC IMRT, around 60% of the PGs are overdosed of 4 Gy. Weekly replanning decreased the PG mean dose by 5 Gy, and therefore by 11% the xerostomia risk.

[1]  Randall K Ten Haken,et al.  Parotid gland function after radiotherapy: the combined michigan and utrecht experience. , 2008, International journal of radiation oncology, biology, physics.

[2]  J. Sham,et al.  Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.

[3]  Weiguo Lu,et al.  Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. , 2008, International journal of radiation oncology, biology, physics.

[4]  J. Bourhis,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.

[5]  S. Porter,et al.  Xerostomia in head and neck malignancy. , 2010, Oral oncology.

[6]  Radhe Mohan,et al.  Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get? , 2007, International journal of radiation oncology, biology, physics.

[7]  Jan-Jakob Sonke,et al.  Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer , 2013, BMC Cancer.

[8]  J. Pignon,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer , 2001 .

[9]  L. R. Dice.  Measures of the Amount of Ecologic Association Between Species , 1945 .

[10]  F. Lohr,et al.  Impact of Residual Setup Error on Parotid Gland Dose in Intensity-Modulated Radiation herapy with or without Planning Organ-at-Risk Margin , 2009, Strahlentherapie und Onkologie.

[11]  Radhe Mohan,et al.  Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. , 2004, International journal of radiation oncology, biology, physics.

[12]  Pascal Haigron,et al.  Surface-Constrained Nonrigid Registration for Dose Monitoring in Prostate Cancer Radiotherapy , 2014, IEEE Transactions on Medical Imaging.

[13]  M. Chambers,et al.  Radiation‐induced xerostomia , 2007, Head & neck.

[14]  Yasumasa Nishimura,et al.  Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT. , 2005, Japanese journal of clinical oncology.

[15]  Qiuwen Wu,et al.  Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. , 2009, International journal of radiation oncology, biology, physics.

[16]  Shih-Neng Yang,et al.  Impact of body-mass factors on setup displacement in patients with head and neck cancer treated with radiotherapy using daily on-line image guidance , 2014, Radiation Oncology.

[17]  Giovanna Rizzo,et al.  Density variation of parotid glands during IMRT for head-neck cancer: correlation with treatment and anatomical parameters. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  P. Lambin,et al.  Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  T. Vercauteren,et al.  Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Yasumasa Nishimura,et al.  Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[22]  J. Gérard,et al.  [Good knowledge and respect for dosage tolerance of organs at risk and healthy tissues is one of the major aspects of the profession of radiotherapeutic oncology]. , 2010, Cancer Radiothérapie.

[23]  J. Lyman.  Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.

[24]  Harm Meertens,et al.  Volume effects and region-dependent radiosensitivity of the parotid gland. , 2005, International journal of radiation oncology, biology, physics.

[25]  Ik Jae Lee,et al.  Is There a Clinical Benefit to Adaptive Planning During Tomotherapy in Patients with Head and Neck Cancer at Risk for Xerostomia? , 2012, American journal of clinical oncology.

[26]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[27]  T. Schuster,et al.  Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer , 2012, Strahlentherapie und Onkologie.

[28]  S. Leung,et al.  Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  H. Kampinga,et al.  Rescue of Salivary Gland Function after Stem Cell Transplantation in Irradiated Glands , 2008, PloS one.

[30]  J. L. Lacau St Guily,et al.  Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database , 2010, Head & neck oncology.

[31]  F. Mornex,et al.  [Normal tissue tolerance to external beam radiation therapy: lung]. , 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[32]  Jean-Philippe Thirion,et al.  Image matching as a diffusion process: an analogy with Maxwell's demons , 1998, Medical Image Anal..

[33]  Jean-François Daisne,et al.  Atlas-based automatic segmentation of head and neck organs at risk and nodal target volumes: a clinical validation , 2013, Radiation oncology.

[34]  Lei Dong,et al.  Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  R Mohan,et al.  Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. , 2000, International journal of radiation oncology, biology, physics.

[36]  A. Vissink,et al.  Secondary radiation damage as the main cause for unexpected volume effects: a histopathologic study of the parotid gland. , 2006, International journal of radiation oncology, biology, physics.

[37]  Ping Xia,et al.  Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.

[38]  Benoît Macq,et al.  Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  Xavier Geets,et al.  Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort? , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  H. Sack,et al.  Evaluation of Time, Attendance of Medical Staff, and Resources During Radiotherapy for Head and Neck Cancer Patients , 2011, Strahlentherapie und Onkologie.

[41]  Ping Xia,et al.  Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[42]  N. Willich,et al.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients , 2011, Strahlentherapie und Onkologie.

[43]  R. Henriksson,et al.  Increase in mast cells and hyaluronic acid correlates to radiation-induced damage and loss of serous acinar cells in salivary glands: the parotid and submandibular glands differ in radiation sensitivity. , 1994, British Journal of Cancer.